- Report
- May 2026
- 376 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 271 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 262 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 182 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 182 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 164 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 282 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 274 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 193 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 193 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 268 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- May 2026
- 278 Pages
Global
From €5164EUR$5,850USD£4,459GBP
- Report
- January 2026
- 186 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- January 2026
- 180 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- January 2026
- 185 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- August 2025
- 188 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- May 2025
- 180 Pages
Global
From €3972EUR$4,500USD£3,430GBP
- Report
- September 2025
- 150 Pages
Global
From €3530EUR$3,999USD£3,048GBP
- Report
- August 2025
- 146 Pages
Global
From €3530EUR$3,999USD£3,048GBP
- Report
- June 2025
- 135 Pages
Global
From €3530EUR$3,999USD£3,048GBP

The Vaccine Development market is a subset of the Vaccines industry, which focuses on the research, development, and production of vaccines. Vaccines are biological preparations that provide active acquired immunity to a particular disease. Vaccine development involves the identification of antigens, the development of a vaccine formulation, and the production of the vaccine. Vaccine development is a complex process that requires significant resources and expertise.
The Vaccine Development market is highly competitive, with many companies competing to develop and produce vaccines. Companies in the market include Merck & Co., GlaxoSmithKline, Sanofi, Pfizer, Johnson & Johnson, and Novavax. Show Less Read more